Mahone, EM, Miller, TL, Koth, CW, Mostofsky, SH, Golberg, M, & Denckla, MB. (2003). Differences between WISC-R and WISC-III performance scale among children with ADHD. Psychology in the Schools, 40(4), 331-340.
Cutting, LE, Koth, CW, Mahone, EM, Denckla, MB (2003). Evidence for unexpected weaknesses in learning in children with attention deficit hyperactivity disorder without reading disabilities. Journal of Learning Disabilities, 36, 259-269.
Cutting, LE, Cooper, KL, Koth, CW, Mostofsky, SH, Kates, WR, Denckla, MB, & Kaufmann WE. (2002). Megalencephaly in NF1: Predominately white matter contribution and mitigation by ADHD. Neurology, 59, 1388-94.
Cutting, LE, Huang, GH, Zeger, SL, Koth, CW, & Denckla, MB. (2001). Specific cognitive functions remain "spared" and "impaired" over time in children with Neurofibromatosis Type 1: Growth curve analyses of neuropsychological profiles, Journal of the International Neuropsychological Society, 8, 838-846.
Mahone, EM, Koth, CW, Cutting, LE, Singer, HS, & Denckla, MB. (2001). Executive function in fluency and recall measures among children with Tourette Syndrome or ADHD. Journal of the International Neurology Society, 7, 102-111.
Koth CW, Cutting LE, & Denckla MB. (2000). The association of Neurofibromatosis Type 1 and Attention Deficit Hyperactivity Disorder. Child Neuropsychology, 6, 185-194.
Wang, PY, Kaufmann, WE, Koth, CW, Denckla, MB, & Barker, PB. (2000). Thalamic Involvement in Neurofibromatosis Type 1: Evaluation with Proton MR Spectroscopic Imaging. Annals of Neurology, 47, 477-487.
Cutting, LE, Koth, CW, Burnette, C, Abrams, MT, Kaufmann, WE, & Denckla, MB. (2000). The relationship of cognitive functioning, whole brain volumes, and T-2 weighted hyperintensities in Neurofibromatosis Type 1. Journal of Child Neurology, 15, 157-160.
Cutting, LE, Koth, CW, & Denckla, MB. (2000). How children with Neurofibromatosis Type 1 differ from "typical" learning disabled clinic attenders: non-verbal learning disabilities revisited. Developmental Neuropsychology, 17, 29-47.
